Chemotherapy for enterohemorrhagic Escherichia coli O157 : H infection in a mouse model

Citation
K. Yoshimura et al., Chemotherapy for enterohemorrhagic Escherichia coli O157 : H infection in a mouse model, FEMS IM MED, 26(2), 1999, pp. 101-108
Citations number
20
Categorie Soggetti
Immunology
Journal title
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
ISSN journal
09288244 → ACNP
Volume
26
Issue
2
Year of publication
1999
Pages
101 - 108
Database
ISI
SICI code
0928-8244(199911)26:2<101:CFEECO>2.0.ZU;2-M
Abstract
The aim of this study is to evaluate the therapeutic effect of the antimicr obial agents, fosfomycin (FOM), minocycline (MINO), kanamycin (KM) and norf loxacin (NFLX) in the enterohemorrhagic Escherichia coli (EHEC) infected mo use model which we established previously (Infect. Immun. 62 (1994) 3447-34 53). Each of the antimicrobial agents, 1/16 LD50, was given to the mice per os (p.o.) or intraperitoneally (i.p.) for 3 days after bacterial inoculati on and then we observed their mortality rate for 2 weeks. The mortality rat es of mice administered with MINO (p.o./i.p.), KM (p.o.), NFLX (p.o./i.p.) were significantly lower than those of the control group. Both the bacteria ! number and VT2c level in the feces of the FOM group were lower than those of the NFLX group on day 1, but reversed on day 3. In an in vitro experime nt, each of the four drugs in combination with mitomycin C (MMC) caused a m ore significant decrease in the bacterial number than sole MMC, and they co nsequently indicated the suppressive effect on the release of VT2c. (C) 199 9 Federation of European Microbiological Societies. Published by Elsevier S cience B.V. All rights reserved.